Andrew is a Senior Counsel in the Patents team and offers expert counsel on contentious patent and regulatory matters. Leveraging his previous experience as a medicinal chemist in the pharmaceutical industry, he is particularly focused on advising companies within the life sciences sector.
Declaratory Relief in the English Patents Court, Bio-Science Law Review, 2016, p 123-128
Patents Overhauled: Impact of the America Invents Act on the Pharmaceutical Industry (co-author), European Biopharmaceutical Review, Spring 2015
New and Approved: The New EU Clinical Trials Regulation (co-author), European Pharmaceutical Contractor, December 2014 p 50-53
von mehreren Autoren
Brexit and beyond – Wellcome's recommendations from the Future Partnership Project
von Andrew Payne
Licence held to be exclusive despite option
von Andrew Payne
von mehreren Autoren
von mehreren Autoren
von mehreren Autoren
von Emma Allen
von Samy Akeb
von Alison Dennis und Alice Matthews
von mehreren Autoren
von Edward Spencer